Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Suzanne C. Malfair Taylor"'
Autor:
Stuart Peacock, Doug Coyle, Suzanne C. Malfair Taylor, Nicole Mittmann, Paul Oh, Murray Krahn, Don Husereau, Philip Jacobs, Deborah A. Marshall, Natasha B. Leighl, William K. Evans, Pierre K. Isogai, Angela Rocchi, Heather-Jane Au, Christopher J. Longo
Publikováno v:
Value in Health. 15:580-585
Objective Specific methodological challenges are often encountered during cancer-related economic evaluations. The objective of this study was to provide specific guidance to analysts on the methods for the conduct of high-quality economic evaluation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::325529882970a2f777e1d58cfd94cc88
https://doi.org/10.1016/j.jval.2011.12.006
https://doi.org/10.1016/j.jval.2011.12.006
Autor:
Caroline Lohrisch, Stephen Chia, Laurel Kovacic, Suzanne C. Malfair Taylor, Caroline Speers, Lindsay Hedden, Stuart Peacock, Susan E. O'Reilly
Publikováno v:
The Oncologist. 17:164-171
Background. Among women with surgically removed, high-risk HER-2/neu-positive breast cancer, trastuzumab has demonstrated significant improvements in disease-free and overall survival. The objective of this study is to evaluate the cost-effectiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2a7db0f04c4f265cea3408dd962d17f
https://doi.org/10.1634/theoncologist.2011-0379
https://doi.org/10.1634/theoncologist.2011-0379
Autor:
Suzanne C. Malfair Taylor, Vincent H Mabasa, Veronika Moravan, Christina Cy Chu, Karissa Johnston, M. Knowling, Stuart Peacock
Publikováno v:
Journal of Oncology Pharmacy Practice. 14:105-112
Background. This cost-effectiveness analysis of imatinib in British Columbia Cancer Agency (BCCA) patients with advanced gastrointestinal stromal tumors (GIST) was performed to justify funding. Patients and Methods. A pragmatic, retrospective review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1a1ce134c8f169ba30aaa1a67419d07
https://doi.org/10.1177/1078155208088695
https://doi.org/10.1177/1078155208088695
Autor:
Caroline Speers, Ivo A. Olivotto, Karen A. Gelmon, Jeff Barnett, Caroline A. Lohrisch, Charles Paltiel, Suzanne C. Malfair Taylor
Publikováno v:
Journal of Clinical Oncology. 24:4888-4894
Purpose To determine if time to start of adjuvant chemotherapy after curative surgery influences survival in early-stage breast cancer. Patients and Methods A retrospective review was conducted of 2,594 patients receiving adjuvant chemotherapy for st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db3e18771793d55128f52911755ef606
https://doi.org/10.1200/jco.2005.01.6089
https://doi.org/10.1200/jco.2005.01.6089
Publikováno v:
Journal of Oncology Pharmacy Practice. 12:105-111
Study objectives. To re-evaluate the cost effectiveness and median overall survival (OS) achieved in patients with recurrent malignant gliomas treated with temozolomide in British Columbia, as compared to previous lomustine use in the same patient po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36459598f832c0152ce9927b7e2c19d6
https://doi.org/10.1177/1078155206069161
https://doi.org/10.1177/1078155206069161
Publikováno v:
Annals of Pharmacotherapy. 38:1406-1411
BACKGROUND: Many patients with cancer (45–60%) use natural health products (NHPs). Pharmacists often find it difficult to advise these patients effectively. OBJECTIVE: To explore pharmacists' perceptions of the information needed to advise cancer p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f82c04bea32ca59484d55c1d940f0965
https://doi.org/10.1345/aph.1e062
https://doi.org/10.1345/aph.1e062
Publikováno v:
Journal of Oncology Pharmacy Practice. 8:131-134
Transient nasopharyngeal discomfort induced by cyclophosphamide infusion has been described in a few previous case reports. There is a theory that these adverse effects may have a cholinergic mechanism. Several measures have been reported to be succe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8588579c517e8e14ac22b6e2b481c915
https://doi.org/10.1191/1078155202jp100cr
https://doi.org/10.1191/1078155202jp100cr
Autor:
Suzanne C. Malfair Taylor
Publikováno v:
Journal of Oncology Pharmacy Practice. 4:125-128
The first European conference on the economics of cancer was held in Brussels, Belgium on November 19-21, 1997. This international meeting was organized under the European Organization for Research and Treat ment of Cancer. Approximately 300 particip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f98448e15c36f5c813c4cdc688769d7d
https://doi.org/10.1177/107815529800400205
https://doi.org/10.1177/107815529800400205
Autor:
Suzanne C. Malfair Taylor, Stuart Peacock, Ian Cromwell, Kimberly van der Hoek, Barbara Melosky
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 76(3)
Erlotinib has been approved as a third-line treatment for advanced non-small-cell lung cancer (NSCLC) in British Columbia (BC). A cost-effectiveness analysis was conducted to compare costs and effectiveness in patients who received third-line erlotin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e814caf2b0b18475be820c43547b48c
https://pubmed.ncbi.nlm.nih.gov/22503286
https://pubmed.ncbi.nlm.nih.gov/22503286
Publikováno v:
Expert opinion on drug metabolismtoxicology. 5(11)
Raltitrexed was developed as a direct and specific inhibitor of thymidylate synthase. Early clinical trials showed similar activity to 5-fluorouracil (5-FU), mainly in metastatic colorectal cancer (MCRC).Pharmacokinetics are summarized and Phase III
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6cab72c796d5d5a7eedf1e6318d4273
https://pubmed.ncbi.nlm.nih.gov/19863453
https://pubmed.ncbi.nlm.nih.gov/19863453